216 related articles for article (PubMed ID: 35122408)
1. Metastable Iron Sulfides Gram-Dependently Counteract Resistant Gardnerella Vaginalis for Bacterial Vaginosis Treatment.
Fang L; Ma R; Gao XJ; Chen L; Liu Y; Huo Y; Wei T; Wang X; Wang Q; Wang H; Cui C; Shi Q; Jiang J; Gao L
Adv Sci (Weinh); 2022 Apr; 9(10):e2104341. PubMed ID: 35122408
[TBL] [Abstract][Full Text] [Related]
2. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
[TBL] [Abstract][Full Text] [Related]
3. Screening of Compounds against Gardnerella vaginalis Biofilms.
Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
[TBL] [Abstract][Full Text] [Related]
4. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
[TBL] [Abstract][Full Text] [Related]
5. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
Machado A; Cerca N
J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
[TBL] [Abstract][Full Text] [Related]
6. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes.
Patterson JL; Stull-Lane A; Girerd PH; Jefferson KK
Microbiology (Reading); 2010 Feb; 156(Pt 2):392-399. PubMed ID: 19910411
[TBL] [Abstract][Full Text] [Related]
7. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
[TBL] [Abstract][Full Text] [Related]
8. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
9. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms.
Castro J; Cerca N
Anaerobe; 2015 Dec; 36():56-9. PubMed ID: 26505928
[TBL] [Abstract][Full Text] [Related]
10. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
[TBL] [Abstract][Full Text] [Related]
11. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
[TBL] [Abstract][Full Text] [Related]
12. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
Hymes SR; Randis TM; Sun TY; Ratner AJ
J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Effects of Sophora flavescens Alkaloids on Metronidazole-Resistant Gardnerella vaginalis in Planktonic and Biofilm Conditions.
Fan L; Liu Z; Zhang Z; Bai H
Curr Microbiol; 2023 Jun; 80(8):263. PubMed ID: 37382659
[TBL] [Abstract][Full Text] [Related]
14. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
Aroutcheva AA; Simoes JA; Behbakht K; Faro S
Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Data on the
Landlinger C; Oberbauer V; Podpera Tisakova L; Schwebs T; Berdaguer R; Van Simaey L; Vaneechoutte M; Corsini L
Antimicrob Agents Chemother; 2022 May; 66(5):e0231921. PubMed ID: 35416708
[TBL] [Abstract][Full Text] [Related]
16. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
17. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.
Schwebke JR; Muzny CA; Josey WE
J Infect Dis; 2014 Aug; 210(3):338-43. PubMed ID: 24511102
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.
Gilbert NM; Lewis WG; Lewis AL
PLoS One; 2013; 8(3):e59539. PubMed ID: 23527214
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors.
Castro J; Machado D; Cerca N
ISME J; 2019 May; 13(5):1306-1317. PubMed ID: 30670827
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of virulence factors & biotypes of
Nisha K; Antony B; Udayalaxmi J
Indian J Med Res; 2019 Jan; 149(1):57-61. PubMed ID: 31115376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
